GeoPolitics Pulse

The Heartbeat of World events

European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Padcev …

by ·

Approval of KEYTRUDA plus enfortumab vedotin brings a potential new first-line standard of care to these patients in the European Union.Read More

Related posts:

  1. European Commission Approves Astellas’ PADCEV™ (enfortumab vedotin) in Combination …
  2. European Commission Approves Astellas’ PADCEV TM (enfortumab vedotin) in …
  3. Enfortumab vedotin plus pembrolizumab approved in Japan for urothelial carcinoma
  4. Summit Declares NSCLC Victory Over Keytruda, Analysts Advise Caution With China-Only Data
  5. European Commission Approves Dostarlimab Plus Chemo for All Advanced/Recurrent …